Categories AlphaGraphs, Earnings, Health Care
AMGN Earnings: Everything you need to know about Amgen’s Q1 results
Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm also provided guidance for fiscal 2023.
Unadjusted earnings decreased to $3.98 per share in the March quarter from $4.25 per share in the year-ago period. The reported net income was $2.84 billion or $5.28 per share in the latest quarter, compared to $1.48 billion or $2.68 per share in the same period of last year.
Total revenues edged down by 2% from last year to $6.11 billion during the three-month period. A 2% increase in product sales was more than offset by a decline in Other Revenue from the company’s COVID-19 manufacturing collaboration.
Prior performance
Most Popular
StubHub Holdings set to enter public markets. Here’s what to expect
After a modest start to the year, the IPO market is witnessing an increase in activity led by technology and healthcare companies. StubHub Holdings, a leading online ticket marketplace for
Can Beyond Meat (BYND) overcome its persistent challenges?
Shares of Beyond Meat, Inc. (NASDAQ: BYND) stayed red on Tuesday. The stock has dropped 19% over the past three months. The plant-based meat company continues to struggle in terms
CarMax (KMX) likely to report strong earnings growth for Q4 2025
After reporting robust earnings growth for the third quarter, CarMax, Inc. (NYSE: KMX) is preparing to publish Q4 results next week. Over the years, the company has fostered customer loyalty
